Mirror Biologics, Inc.
Clinical trials sponsored by Mirror Biologics, Inc., explained in plain language.
-
Experimental immunotherapy combo for tough colorectal cancer trial pulled before start
Disease control TerminatedThis study was designed to test an experimental immunotherapy called AlloStim combined with a checkpoint inhibitor (avelumab) in people with advanced colorectal cancer that had stopped responding to multiple prior treatments. The trial was withdrawn before any participants were e…
Phase: PHASE2 • Sponsor: Mirror Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New immunotherapy aims to fight advanced liver cancer
Disease control TerminatedThis study tests an immunotherapy called AlloStim against standard treatments (sorafenib, lenvatinib, or chemotherapy) in 150 Asian adults with advanced liver cancer that cannot be treated with surgery or local therapies. Participants are randomly assigned to receive either AlloS…
Phase: PHASE2, PHASE3 • Sponsor: Mirror Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC